Literature DB >> 21186282

Comparison of open three-field and minimally-invasive esophagectomy for esophageal cancer.

Yongshan Gao1, Yun Wang, Longqi Chen, Yongfan Zhao.   

Abstract

The aim was to compare the early outcomes between thoracoscopic and laparoscopic esophagectomy (TLE) and open three-field esophagectomy for esophageal cancer. We retrospectively analyzed clinical data from 96 patients with esophageal cancer who underwent TLE, and 78 patients who underwent open three-field esophagectomy from March 2008 to September 2010. All the operations were successful. There was no significant difference between TLE and open three-field esophagectomy with regard to the number of lymph nodes procured (17.75±5.56 vs. 18.03±6.20, P>0.05), complications (32.3% vs. 46.2%, P>0.05), and operative mortality (2.1% vs. 3.8%, P>0.05). However, hospital stay was significantly shorter in the TLE group than the open esophagectomy group (12.64±8.82 vs. 17.53±6.40 days, P<0.01), and the TLE group had significantly less blood loss (346.68±41.13 vs. 519.26±47.74 ml, P<0.01). This showed that TLE for esophageal cancer offers results as good as or better than those with open three-field esophagectomy.

Entities:  

Mesh:

Year:  2010        PMID: 21186282     DOI: 10.1510/icvts.2010.258632

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  23 in total

1.  Albert-Lembert versus hybrid-layered suture in hand sewn end-to-end cervical esophagogastric anastomosis after esophageal squamous cell carcinoma resection.

Authors:  Fan Feng; Li Sun; Guanghui Xu; Liu Hong; Jianjun Yang; Lei Cai; Guocai Li; Man Guo; Xiao Lian; Hongwei Zhang
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

Review 2.  Combined thoracoscopic-laparoscopic esophagectomy versus open esophagectomy: a meta-analysis of outcomes.

Authors:  Wei Guo; Xiao Ma; Su Yang; Xiaoli Zhu; Wei Qin; Jiaqing Xiang; Toni Lerut; Hecheng Li
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

Review 3.  Minimally invasive esophagectomy for esophageal cancer: an updated review.

Authors:  Masayuki Watanabe; Yoshifumi Baba; Yohei Nagai; Hideo Baba
Journal:  Surg Today       Date:  2012-08-28       Impact factor: 2.549

4.  Comparison of outcomes of open and minimally invasive esophagectomy in 183 patients with cancer.

Authors:  Fanyu Meng; Yin Li; Haibo Ma; Ming Yan; Ruixiang Zhang
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

5.  Laparoscopic and thoracoscopic esophagectomy with intrathoracic anastomosis for middle or lower esophageal carcinoma.

Authors:  Bo Ai; Zheng Zhang; Yongde Liao
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

Review 6.  Minimally invasive esophagectomy performed with the patient in a prone position: a systematic review.

Authors:  Kazuo Koyanagi; Soji Ozawa; Yuji Tachimori
Journal:  Surg Today       Date:  2015-04-10       Impact factor: 2.549

7.  Survival and quality of life after minimally invasive esophagectomy: a single-surgeon experience.

Authors:  Abhishek Sundaram; Juan C Geronimo; Brittany L Willer; Masato Hoshino; Zachary Torgersen; Arpad Juhasz; Tommy H Lee; Sumeet K Mittal
Journal:  Surg Endosc       Date:  2011-08-19       Impact factor: 4.584

8.  Impact of surgical approach on perioperative and long-term outcomes following esophagectomy for esophageal cancer.

Authors:  Negar Ahmadi; Agnes Crnic; Andrew J Seely; Sudhir R Sundaresan; P James Villeneuve; Donna E Maziak; Farid M Shamji; Sebastien Gilbert
Journal:  Surg Endosc       Date:  2017-10-24       Impact factor: 4.584

9.  Outcomes following laparoscopic transhiatal esophagectomy for esophageal cancer.

Authors:  J Christian Cash; Joerg Zehetner; Bobak Hedayati; Nikolai A Bildzukewicz; Namir Katkhouda; Rodney J Mason; John C Lipham
Journal:  Surg Endosc       Date:  2013-10-08       Impact factor: 4.584

10.  Extended lymphadenectomy in esophageal cancer is debatable.

Authors:  Fernando A M Herbella; Rafael M Laurino Neto; Marco E Allaix; Marco G Patti
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.